Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vincent Desfontaine
Observed names:
Desfontaine, V.,
Desfontaine, Vincent,
V. Desfontaine
Institutions:
Centre Hospitalier Universitaire Vaudois,
DSM-Firmenich AG (Switzerland),
University of Lausanne
Observed institutions:
University of Geneva,
Centre Hospitalier Universitaire Vaudois,
DSM-Firmenich AG (Switzerland),
University of Lausanne
ORCID:
0000-0002-2231-4946
Observed ORCID:
0000-0002-2231-4946
OpenAlex ID:
A5081939305
Supercritical fluid chromatography in pharmaceutical analysis
2015
·
Vincent Desfontaine
, Davy Guillarme
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
257
What are the current solutions for interfacing supercritical fluid chromatography and mass spectrometry?
2018
·
Davy Guillarme
, Vincent Desfontaine
, et al.
·
Journal of Chromatography B
·
110
Applicability of supercritical fluid chromatography – mass spectrometry to metabolomics. I – Optimization of separation conditions for the simultaneous analysis of hydrophilic and lipophilic substances
2018
·
Vincent Desfontaine
, Gioacchino Luca Losacco
, et al.
·
Journal of Chromatography A
·
108
A systematic investigation of sample diluents in modern supercritical fluid chromatography
2017
·
Vincent Desfontaine
, Abhijit Tarafder
, et al.
·
Journal of Chromatography A
·
91
Liquid chromatography and supercritical fluid chromatography as alternative techniques to gas chromatography for the rapid screening of anabolic agents in urine
2016
·
Vincent Desfontaine
, Lucie Nováková
, et al.
·
Journal of Chromatography A
·
68
First inter-laboratory study of a Supercritical Fluid Chromatography method for the determination of pharmaceutical impurities
2018
·
Amandine Dispas
, Roland Marini
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
64
PDF
Quantitative determination of salbutamol sulfate impurities using achiral supercritical fluid chromatography
2016
·
Amandine Dispas
, Vincent Desfontaine
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
60
Fast and sensitive supercritical fluid chromatography – tandem mass spectrometry multi-class screening method for the determination of doping agents in urine
2016
·
Lucie Nováková
, Vincent Desfontaine
, et al.
·
Analytica Chimica Acta
·
60
Systematic evaluation of matrix effects in supercritical fluid chromatography versus liquid chromatography coupled to mass spectrometry for biological samples
2018
·
Vincent Desfontaine
, Francesca Capetti
, et al.
·
Journal of Chromatography B
·
50
Development and validation of a multiplex UHPLC‐MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV
2020
·
Perrine Courlet
, Susana Alves Saldanha
, et al.
·
Journal of Mass Spectrometry
·
45
PDF
Possibilities of retention modeling and computer assisted method development in supercritical fluid chromatography
2015
·
Eva Tyteca
, Vincent Desfontaine
, et al.
·
Journal of Chromatography A
·
45
Comparison of liquid chromatography and supercritical fluid chromatography coupled to compact single quadrupole mass spectrometer for targeted in vitro metabolism assay
2014
·
Dany Spaggiari
, Florence Mehl
, et al.
·
Journal of Chromatography A
·
45
Evaluation of innovative stationary phase ligand chemistries and analytical conditions for the analysis of basic drugs by supercritical fluid chromatography
2016
·
Vincent Desfontaine
, Jean-Luc Veuthey
, et al.
·
Journal of Chromatography A
·
41
SFC–MS Versus RPLC–MS for Drug Analysis in Biological Samples
2015
·
Vincent Desfontaine
, Lucie Nováková
, et al.
·
Bioanalysis
·
35
Hyphenated Detectors
2017
·
V. Desfontaine
, J.-L. Veuthey
, et al.
·
Elsevier eBooks
·
22
Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma
2019
·
Dany Spaggiari
, Vincent Desfontaine
, et al.
·
PLoS ONE
·
21
PDF
UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV
2019
·
Perrine Courlet
, Dany Spaggiari
, et al.
·
Journal of Chromatography B
·
17
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis
2022
·
T. Mercier
, V. Desfontaine
, et al.
·
Journal of Chromatography B
·
13
Development of a LC–MS/MS method for the determination of isomeric glutamyl peptides in food ingredients
2017
·
Vincent Desfontaine
, Alexandre Goyon
, et al.
·
Journal of Separation Science
·
12
Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine
2022
·
Vincent Desfontaine
, Sylvie Guinchard
, et al.
·
Journal of Chromatography B
·
9
PDF
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies
2023
·
Paulina Biniecka
, Saki Matsumoto
, et al.
·
Molecules
·
8
PDF
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration
2023
·
Paul Thoueille
, Susana Alves Saldanha
, et al.
·
Journal of Antimicrobial Chemotherapy
·
4
PDF
Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the monitoring of temsavir plasma concentrations in people living with HIV
2022
·
Paul Thoueille
, Ulrich Seybold
, et al.
·
Journal of Chromatography B
·
3
PDF
5. What is the potential of SFC-MS for doping control analysis?
2018
·
Vincent Desfontaine
, Raul Nicoli
, et al.
·
De Gruyter eBooks
·
1
Human prostaglandin reductases dearomatize and inactivate benzothiazinone antitubercular drugs
2026
·
Myriam Briki
, Caroline A Wagner
, et al.
·
EMBO Molecular Medicine
PDF
Show more works
View as search
Works count:
35
Citation count:
1,189
H-index:
17
I10-index:
19
Year
Topic
Type